MDCG’s Meeting Heralds The Next Chapter In An Increasingly Dramatic EU Medtech Story
Executive Summary
If the current EU medtech regulatory situation were a book, it would be difficult to know what the denouement would be. But right now, the whole sector urgently wants to see a chapter that will hint at a happy ending.